Common placeholders (all forms)
{{spupCode}}
{{protocolId}}
{{protocolTitle}}
{{principalInvestigator}}
{{studySite}}
{{sponsor}}
{{institution}}
{{submissionDate}}
{{reviewerName}}
{{typeOfReview}} // expedited | full
{{reviewerEmail}} (if available)
{{formType}} // protocol-review | informed-consent | exemption-checklist | iacuc-review
{{status}} // draft | submitted | approved | rejected
{{submittedAt}} // YYYY-MM-DD HH:mm (blank if draft)
{{recommendation}} // Approved | Minor Modifications Required | Major Modifications Required | Disapproved (where applicable)
{{justification}} // free text where applicable

Protocol Review Assessment (Form 06B)
Section 1: SOCIAL VALUE
{{SocialValue}}, {{SocialValueComments}} // 1. SOCIAL VALUE - Does the study have scientific or social value?

Section 2: SCIENTIFIC SOUNDNESS
{{StudyObjectives}}, {{StudyObjectivesComments}} // 2.1 Study Objectives - Is/are the proposal's scientific question/s reasonable?
{{LiteratureReview}}, {{LiteratureReviewComments}} // 2.2 Literature Review - Does the protocol adequately present informational background as to the result of previous studies prior to human experimentation?
{{ResearchDesign}}, {{ResearchDesignComments}} // 2.3 Research and Sampling design - Is the study design, sampling method and techniques appropriate?
{{DataCollection}}, {{DataCollectionComments}} // 2.4 Specimen/Data Collection, Processing, Storage - Are the procedures in collecting, processing, and storing data adequate?
{{InclusionExclusion}}, {{InclusionExclusionComments}} // 2.5 Inclusion/Exclusion Criteria - Are the features of the target population appropriate?
{{WithdrawalCriteria}}, {{WithdrawalCriteriaComments}} // 2.6 Withdrawal Criteria - Is there a provision for withdrawal from the research?
{{Facilities}}, {{FacilitiesComments}} // 2.7 Facilities/Infrastructure at Study Site - Are the research facilities adequate?
{{InvestigatorQualification}}, {{InvestigatorQualificationComments}} // 2.8 Investigator's Qualification, Competence, and Experience - Is/are the investigator/s adequately trained and do they have sufficient experience?

Section 3: ETHICAL SOUNDNESS
{{PrivacyConfidentiality}}, {{PrivacyConfidentialityComments}} // 3.1 Privacy and Confidentiality Safeguards - Does the research ensure to protect privacy and confidentiality of participant information?
{{ConflictOfInterest}}, {{ConflictOfInterestComments}} // 3.2 Conflict of Interest - Does the research ensure mechanism of management of conflict arising from financial, familial, or proprietary considerations from PI, sponsor, or the study site?
{{HumanParticipants}}, {{HumanParticipantsComments}} // 3.3 Involvement of Human Participants - Does the research need to be carried out with human participants?
{{VulnerablePopulations}}, {{VulnerablePopulationsComments}} // 3.4 Involvement of Vulnerable Populations - Does the study involve individuals who belong to vulnerable group?
{{VoluntaryRecruitment}}, {{VoluntaryRecruitmentComments}} // 3.5 Participant Selection-voluntary, non-coercive recruitment - Are appropriate mechanisms in place to protect above individual in vulnerable group?
{{RiskBenefit}}, {{RiskBenefitComments}} // 3.6 Risk-Benefit Ratio - Does the protocol adequately address the risk/ benefit balance?
{{InformedConsent}}, {{InformedConsentComments}} // 3.7 Informed Consent Process - Is the informed consent procedure/ assent form adequately and culturally appropriate?
{{CommunityConsiderations}}, {{CommunityConsiderationsComments}} // 3.8 Community Considerations - Does the study offer substantial and relevant contribution to local communities and address possible stigma or draining of local capacity?
{{CollaborativeTerms}}, {{CollaborativeTermsComments}} // 3.9 Collaborative Study Terms of Reference - Does the study present clear terms on IP rights, publication rights, information and responsibility sharing, transparency, and capacity building?


Informed Consent Assessment (Form 06C)
17 guide questions (Yes/No/Unable + comments):
{{q1}}, {{q1Comments}} // 1. Does the Informed Consent document state that the procedures are primarily intended for research?
{{q2}}, {{q2Comments}} // 2. Are procedures for obtaining Informed Consent appropriate?
{{q3}}, {{q3Comments}} // 3. Does the Informed Consent document contain comprehensive and relevant information?
{{q4}}, {{q4Comments}} // 4. Is the information provided in the protocol consistent with those in the consent form?
{{q5}}, {{q5Comments}} // 5. Are study related risks mentioned in the consent form?
{{q6}}, {{q6Comments}} // 6. Is the language in the Informed Consent document understandable?
{{q7}}, {{q7Comments}} // 7. Is the Informed Consent translated into the local language/dialect?
{{q8}}, {{q8Comments}} // 8. Is there adequate protection of vulnerable participants?
{{q9}}, {{q9Comments}} // 9. Are the different types of consent forms (assent, legally acceptable representative) appropriate for the types of study participants?
{{q10}}, {{q10Comments}} // 10. Are names and contact numbers from the research team and the SPUP REC in the informed consent?
{{q11}}, {{q11Comments}} // 11. Does the ICF mention privacy & confidentiality protection?
{{q12}}, {{q12Comments}} // 12. Is there any inducement for participation?
{{q13}}, {{q13Comments}} // 13. Is there provision for medical / psychosocial support?
{{q14}}, {{q14Comments}} // 14. Is there provision for treatment of study-related injuries?
{{q15}}, {{q15Comments}} // 15. Is there provision for compensation?
{{q16}}, {{q16Comments}} // 16. Does the ICF clearly describe the responsibilities of the participants?
{{q17}}, {{q17Comments}} // 17. Does the ICF describe the benefits of participating in the research?
{{recommendation}} // Approved | Minor Modifications Required | Major Modifications Required | Disapproved
{{recommendationJustification}}

Exemption Checklist (Form 04A)
Protocol info already in common placeholders
II. Protocol Assessment
{{involvesHumanParticipants}}, {{involvesHumanParticipantsComments}} // 1. Does this research involve human participants?
{{involvesNonIdentifiableTissue}}, {{involvesNonIdentifiableTissueComments}} // 2. Does this research involve use of non-identifiable human tissue/biological samples?
{{involvesPublicData}}, {{involvesPublicDataComments}} // 3. Does this research involve use of non-identifiable publicly available data?
{{involvesInteraction}}, {{involvesInteractionComments}} // 4. Does this research involve interaction with human participants?
{{qualityAssurance}}, {{qualityAssuranceComments}} // 5.1. Institutional quality assurance
{{publicServiceEvaluation}}, {{publicServiceEvaluationComments}} // 5.2. Evaluation of public service program
{{publicHealthSurveillance}}, {{publicHealthSurveillanceComments}} // 5.3. Public health surveillance
{{educationalEvaluation}}, {{educationalEvaluationComments}} // 5.4. Educational evaluation activities
{{consumerAcceptability}}, {{consumerAcceptabilityComments}} // 5.5. Consumer acceptability test
{{surveysQuestionnaire}}, {{surveysQuestionnaireComments}} // 6.1. Surveys and /or questionnaire
{{interviewsFocusGroup}}, {{interviewsFocusGroupComments}} // 6.2. Interviews or focus group discussion
{{publicObservations}}, {{publicObservationsComments}} // 6.3. Public observations
{{existingData}}, {{existingDataComments}} // 6.4. Research which only uses existing data
{{audioVideo}}, {{audioVideoComments}} // 6.5. Audio/video recordings
{{dataAnonymization}} // 7. Will the collected data be anonymized or identifiable? // Anonymized | Identifiable | De-identified
{{foreseeableRisk}}, {{foreseeableRiskComments}} // 8. Is this research likely to involve any foreseeable risk of harm or discomfort to participants; above the level experienced in everyday life? (NEGHRR 2017)

II. Risk Assessment
{{riskVulnerableGroups}}, {{riskVulnerableGroupsComments}} // 9.1. Any vulnerable group/s
{{riskSensitiveTopics}}, {{riskSensitiveTopicsComments}} // 9.2. Sensitive topics that may make participants feel uncomfortable (i.e. sexual behavior, illegal activities, racial biases, etc.)
{{riskUseOfDrugs}}, {{riskUseOfDrugsComments}} // 9.3. Use of Drugs
{{riskInvasiveProcedure}}, {{riskInvasiveProcedureComments}} // 9.4. Invasive procedure (e.g. blood sampling)
{{riskPhysicalDistress}}, {{riskPhysicalDistressComments}} // 9.5. Physical stress/distress, discomfort
{{riskPsychologicalDistress}}, {{riskPsychologicalDistressComments}} // 9.6. Psychological/mental stress/distress
{{riskDeception}}, {{riskDeceptionComments}} // 9.7. Deception of/or withholding information from subjects
{{riskAccessData}}, {{riskAccessDataComments}} // 9.8. Access to data by individuals or organizations other than the investigators.
{{riskConflictInterest}}, {{riskConflictInterestComments}} // 9.9. Conflict of interest issues
{{riskOtherDilemmas}}, {{riskOtherDilemmasComments}} // 9.10. Or any other ethical dilemmas
{{riskBloodSampling}}, {{riskBloodSamplingComments}} // 9.11. Is there any blood sampling involved in the study
{{decision}} // Qualified for Exemption | Unqualified for Exemption
{{decisionJustification}}

IACUC Protocol Review Assessment (Form 06B IACUC)
Protocol info + IACUC specifics:
{{iacucCode}}


Section 1: SCIENTIFIC VALUE
{{ScientificValue}}, {{ScientificValueComments}} // 1. SCIENTIFIC VALUE - Does the study have scientific value?

Section 2: SCIENTIFIC SOUNDNESS (2.1-2.6 only)
{{StudyObjectives}}, {{StudyObjectivesComments}} // 2.1 Study Objectives - Is/are the proposal's scientific question/s reasonable?
{{LiteratureReview}}, {{LiteratureReviewComments}} // 2.2 Literature Review - Does the protocol adequately present informational background as to the result of previous studies prior to human experimentation?
{{ResearchDesign}}, {{ResearchDesignComments}} // 2.3 Research and Sampling design - Is the study design, sampling method and techniques appropriate?
{{DataCollection}}, {{DataCollectionComments}} // 2.4 Specimen/Data Collection, Processing, Storage - Are the procedures in collecting, processing, and storing data adequate?
{{FacilitiesInfrastructure}}, {{FacilitiesInfrastructureComments}} // 2.5 Facilities/Infrastructure at Study Site - Are the research facilities adequate?
{{InvestigatorQualifications}}, {{InvestigatorQualificationsComments}} // 2.6 Investigator's Qualification, Competence, and Experience - Is/are the investigator/s adequately trained and do they have sufficient experience?

Section 3: JUSTIFICATION ON THE USE OF ANIMALS (3.1-3.12)
{{AnimalDescription}}, {{AnimalDescriptionComments}} // 3.1 Animal Description(?)
{{AnimalCareProcedures}}, {{AnimalCareProceduresComments}} // 3.2 Animal Care Procedures(?)
{{AnimalDiet}}, {{AnimalDietComments}} // 3.3 Animal Diet(?)
{{AnimalManipulationMethods}}, {{AnimalManipulationMethodsComments}} // 3.4 Animal Manipulation Methods(?)
{{DosingMethods}}, {{DosingMethodsComments}} // 3.5 Dosing Methods(?)
{{ExpectedOutcomeOrEffects}}, {{ExpectedOutcomeOrEffectsComments}} // 3.6 Expected outcome or Effects(?)
{{CollectionOfBiologicalAgent}}, {{CollectionOfBiologicalAgentComments}} // 3.7 Collection of Biological Agent(?)
{{AnimalExaminationMethods}}, {{AnimalExaminationMethodsComments}} // 3.8 Animal Examination Methods(?)
{{SurgicalProcedures}}, {{SurgicalProceduresComments}} // 3.9 Surgical Procedures(?)
{{HumaneEndpoints}}, {{HumaneEndpointsComments}} // 3.10 Humane Endpoints
{{PotentialHazards}}, {{PotentialHazardsComments}} // 3.11 Potential Hazards
{{WasteDisposal}}, {{WasteDisposalComments}} // 3.12 Waste Disposal
{{recommendation}} // Approved | Minor Modifications Required | Major Modifications Required | Disapproved
{{justification}}
